Eli Lilly to Acquire Versanis Bio, Maker of Obesity Treatment
Wall Street Journal
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional payments if certain milestones are reached.
https://www.wsj.com/articles/eli-lilly-to-acquire-obesity-treatment-maker-versanis-5d92c56d